✦ LIBER ✦

Concurrent Accelerated Hyperfractionated Radiation Therapy and Carboplatin/etoposide in Patients With Malignant Glioma: Long-term break Results of A Phase II Study

✍ Scribed by Branislav Jeremic; Yuta Shibamoto; Danica Grujicic; Miroslav Stojanovic; Biljana Milicic; Aleksandar Dagovic; Jasna Aleksandrovic

Book ID: 110292601
Publisher: Springer US
Year: 2001
Tongue: English
Weight: 54 KB
Volume: 51
Category: Article
ISSN: 0167-594X
DOI: 10.1023/a:1010621400203

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pre-irradiation carboplatin and etoposid

Pre-irradiation carboplatin and etoposide and accelerated hyperfractionated radiation therapy in patients with high-grade astrocytomas: a phase II study

✍ Branislav Jeremic; Yuta Shibamoto; Danica Grujicic; Biljana Milicic; Miroslav St 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 107 KB

Final report of a phase I/II trial of hy

Final report of a phase I/II trial of hyperfractionated and accelerated hyperfractionated radiation therapy with carmustine for adults with supratentorial malignant gliomas: Radiation therapy oncology group study 83-02

✍ Maria Werner-Wasik; Charles B. Scott; Diana F. Nelson; Laurie E. Gaspar; Kevin J 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 825 KB

## BACKGROUND. Efforts to improve local control and survival by increasing the dose of once-daily radiation therapy beyond 70 Gray (Gy) for patients with malignant gliomas have as yet been unsuccessful. Hyperfractionated radiation therapy (HF) should allow for delivery of a higher total dose witho

1136 POSTER Preoperative concurrent chem

1136 POSTER Preoperative concurrent chemotherapy with accelerated hyperfractionated radiotherapy in non-small-cell lung cancer; feasibility, toxicity and long-term results of a phase II study

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 143 KB

P-621 Concurrent hyperfractionated radio

P-621 Concurrent hyperfractionated radiotherapy (Hfx RT) and low-dosedaily carboplatin/paclitaxel (C/P) in patients with early stage (I/II) non-small cell lung cancer (NSCLC). Long-term results of a phase II study

✍ Jeremic, B.; Milicic, B.; Radosavljevic-Asic, G. 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 124 KB

A Long-term Survival Analysis for Phase

A Long-term Survival Analysis for Phase II Study of Postoperative Concurrent Capecitabine and Radiation Therapy for Patients With Stage II/III Rectal Cancer

✍ Lu, N.; Jin, J.; Li, Y.; Wang, S.; Wang, W.; Song, Y.; Liu, Y.; Ren, H.; Fang, H 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 78 KB

Long-term Follow-up of a Prospective Pha

Long-term Follow-up of a Prospective Phase I-II Study of Concurrent Paclitaxel and Radiation Therapy With Hormonal Ablation in Locally Advanced Prostate Cancer

✍ Sanfilippo, N.J.; Taneja, S.S.; Chachoua, A.; Lepor, H.; Formenti, S.C. 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 51 KB